A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
From Cheap Cash to Tax Breaks, EVs in China Get Lots of Love
California Water Reservoirs Are Still Brimming as El Niño Looms
New AI can screen for diabetes in seconds by listening to your voice
Aperia Launches Halo Drive™ to Simplify Tire Pressure Management for Drivers and Fleets
Biden says there is need to address security, economic risks posed by AI
Microsoft Is Trading Near Its Record High. It’s Still Undervalued.
Marvel Snap May 16 Patch Notes: Full List of Changes
Ethereum Software Infrastructure Provider Flashbots Raises $60 Million